Skip to content

Effects of Sleep Body Temperature on Body Composition

Effects of Sleep Body Temperature on Body Composition

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06648109
Enrollment
40
Registered
2024-10-18
Start date
2024-10-20
Completion date
2025-01-30
Last updated
2024-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aldosterone Disorder, Blood Pressure Check (Hypertension Screening), Heart Rate

Brief summary

This will be a crossover controlled trial designed to recruit 40 participants, who will be divided into two groups of 20 subjects each. The participants will be randomly assigned to either Group A or Group B. Group A will receive the sleep electric blanket intervention for a period of 7 days, while Group B will serve as the control group without any additional intervention. After the intervention period, there will be a washout period of 7 days to ensure that any effects of the intervention have subsided before the crossover. Following the washout period, the groups will switch roles: Group B will then receive the sleep electric blanket intervention, and Group A will become the control group. This second phase will also last for 7 days, preceded and followed by the same assessment procedures as the initial phase. This design will allow for a comparison of the intervention's effects against a control period within the same group of participants, enhancing the study's internal validity.

Interventions

Participants were randomized to groups A and B. When the subject's group cohort went through the intervention phase (instead of the control phase), they received a 7-day, 8-hour intervention with an electric blanket +5±1°C above room temperature.

Sponsors

Jinan University Guangzhou
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

This is a crossover controlled trial to recruit 40 people, divided into two groups of 20 subjects each using randomised grouping and named Group A and Group B. Group A will receive the sleep electric blanket intervention for a period of 7 days and Group B will serve as the control group without additional intervention, followed by a washout period of 7 days. A 1-stage baseline as well as a 3-stage follow-up including questionnaires, physical and grip strength measurements, blood index tests, and dormitory environment measurements were required.

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

\- Participants aged 18-30 years, inclusive of both male and female genders.

Exclusion criteria

* Individuals suffering from serious diseases such as heart, liver, kidney, brain, hematopoietic, immune, thyroid, malignant tumors, etc.; * Those with familial hereditary hypertension (both parents are hypertensive) or those diagnosed with hypertension; * Individuals with cognitive or mental impairments that prevent the completion of the questionnaire; * Persons with physical disabilities that hinder normal walking; * Persons who have experienced a weight change of \>3.0 kg within 1 month or \>10 kg within 6 months prior to screening (as per the study in Nutrients. 2020 Oct 21;12(10):3221); * Individuals required to take antibiotics from one week before the trial starts until its conclusion; * Those with habitual diarrhea or who have experienced diarrhea from one week before the trial starts until its end; * Subjects who have participated in other ambient temperature-related trials within the last 6 months; * Individuals with extreme sleep schedules (i.e., not falling asleep between 21:00 and 2:00 a.m. the following morning, or waking up before 5:00 a.m.); * Those with sleep latency (the time it takes to fall asleep after going to bed) greater than one hour; * Pittsburgh Sleep Quality Index (PSQI) scores greater than 16; * Participants who do not sign the informed consent form or are deemed unsuitable by the investigator for any other reason.

Design outcomes

Primary

MeasureTime frameDescription
Blood pressure1monthIncluding systolic blood pressure (SBP) and diastolic blood pressure (DBP), Includes office blood pressure, home blood pressure and ambulatory blood pressure.

Countries

China

Contacts

Primary ContactFangfang Zeng
zengffjnu@126.com+86 13822285635
Backup ContactJiamin Qiu
adniminday@163.com+86 178196663352

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026